Cognitive functions in first degree normative relative of patients with schozophrenia

Background: Schizophrenia is severe disorders and imposes a considerable burden on patients, their families and society. Schizophrenia tends to run in family, like most mental disorder shows complex inheritance. Therefore, it is important to increase our knowledge about the disorder. Cognitive dysfunction is one of the core features of Schizophrenia. This study aims to compare the cognitive function of first degree unaffected relative of patient of schizophrenia and a group of healthy control.Methods: The study include 48 first degree normative relative of patient with Schizophrenia and 48 controls. Compared for age, sex, education level. Cognitive functions of each case and control were assessed using TMT (Trail making Test), Paced auditory serial addition Test (PASAT) and Wisconsin card sorting test (WCST-64).Results: First degree relative performed significantly poorly as compared to controls on Wisconsin card sorting Test-64 (WCST-64). No significant difference was observed in tests performances between first degree relative of Schizophrenia and control group for TMT (trail making test) and Paced auditory serial addition Test (PASAT).Conclusions: The study shows possibility of cognitive impairment in first degree normative relative of Schizophrenia with regards to parameters like poor performance in shifting cognitive sets and poor understanding of test. Nevertheless, it is not clear weather this finding is an enduring trait mark or finding that fluctuates with sample size, nature of case and control

Trends in Outcomes for Neonates Born Very Preterm and Very Low Birth Weight in 11 High-Income Countries

Objective To evaluate outcome trends of neonates born very preterm in 11 high-income countries participating in the International Network for Evaluating Outcomes of neonates. Study design In a retrospective cohort study, we included 154 233 neonates admitted to 529 neonatal units between January 1, 2007, and December 31, 2015, at 24(0/7) to 31(6/7) weeks of gestational age and birth weight <1500 g. Composite outcomes were in-hospital mortality or any of severe neurologic injury, treated retinopathy of prematurity, and bronchopulmonary dysplasia (BPD); and same composite outcome excluding BPD. Secondary outcomes were mortality and individual morbidities. For each country, annual outcome trends and adjusted relative risks comparing epoch 2 (2012-2015) to epoch 1 (2007-2011) were analyzed. Results For composite outcome including BPD, the trend decreased in Canada and Israel but increased in Australia and New Zealand, Japan, Spain, Sweden, and the United Kingdom. For composite outcome excluding BPD, the trend decreased in all countries except Spain, Sweden, Tuscany, and the United Kingdom. The risk of composite outcome was lower in epoch 2 than epoch 1 in Canada (adjusted relative risks 0.78; 95% CI 0.74-0.82) only. The risk of composite outcome excluding BPD was significantly lower in epoch 2 compared with epoch 1 in Australia and New Zealand, Canada, Finland, Japan, and Switzerland. Mortality rates reduced in most countries in epoch 2. BPD rates increased significantly in all countries except Canada, Israel, Finland, and Tuscany. Conclusions In most countries, mortality decreased whereas BPD increased for neonates born very preterm

High oxygen storage capacity and high rates of CO oxidation and NO reduction catalytic properties of Ce<SUB>1-x</SUB>Sn<SUB>x</SUB>O<SUB>2</SUB> and Ce<SUB>0.78</SUB>Sn<SUB>0.2</SUB>Pd<SUB>0.02</SUB>O<SUB>2-&#948;</SUB>

Ce1-xSnxO2 (x = 0.1-0.5) solid solution and its Pd substituted analogue have been prepared by a single step solution combustion method using tin oxalate precursor. The compounds were characterized by X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), transmission electron microscopy (TEM), and H2/temperature programmed redution (TPR) studies. The cubic fluorite structure remained intact up to 50% of Sn substitution in CeO2, and the compounds were stable up to 700 &#176;C. Oxygen storage capacity of Ce1-xSnxO2 was found to be much higher than that of Ce1-xZrxO2 due to accessible Ce4+/Ce3+ and Sn4+/Sn2+ redox couples at temperatures between 200 and 400 &#176;C. Pd2+ ions in Ce0.78Sn0.2Pd0.02O2-&#948; are highly ionic, and the lattice oxygen of this catalyst is highly labile, leading to low temperature CO to CO2 conversion. The rate of CO oxidation was 2 &#956;mol g-1 s-1 at 50 &#176;C. NO reduction by CO with 70% N2 selectivity was observed at 200 &#176;C and 100% N2 selectivity below 260 &#176;C with 1000-5000 ppm NO. Thus, Pd2+ ion substituted Ce1-xSnxO2 is a superior catalyst compared to Pd2+ ions in CeO2, Ce1-xZrxO2, and Ce1-xTixO2 for low temperature exhaust applications due to the involvement of the Sn2+/Sn4+ redox couple along with Pd2+/Pd0 and Ce4+/Ce3+ couples